Found: 83
Select item for more details and to access through your institution.
Editorial: Cancer immunotherapies for hematologic malignancies - NK/CIK/CAR-T perspective.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1434259
- By:
- Publication type:
- Article
CSRP1 gene: a potential novel prognostic marker in acute myeloid leukemia with implications for immune response.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01088-9
- By:
- Publication type:
- Article
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma—Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 12, p. 6431, doi. 10.3390/ijms25126431
- By:
- Publication type:
- Article
Oncogenes and tumor suppressor genes: functions and roles in cancers.
- Published in:
- MedComm, 2024, v. 5, n. 6, p. 1, doi. 10.1002/mco2.582
- By:
- Publication type:
- Article
Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1268652
- By:
- Publication type:
- Article
Inferring the diagnostic potential of 18F-FDG-PET/CT in post-renal transplantation from a unique case harboring multiple rare complications.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1353466
- By:
- Publication type:
- Article
Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03605-1
- By:
- Publication type:
- Article
Liquid Biopsy in Organ Damage: small extracellular vesicle chipbased assessment of polytrauma.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1279496
- By:
- Publication type:
- Article
Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment.
- Published in:
- BMC Medical Genomics, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s12920-023-01724-3
- By:
- Publication type:
- Article
Computational analysis of heat shock proteins and ferroptosis-associated lncRNAs to predict prognosis in acutemyeloid leukemia patients.
- Published in:
- Frontiers in Genetics, 2023, p. 01, doi. 10.3389/fgene.2023.1218276
- By:
- Publication type:
- Article
Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12476, doi. 10.3390/ijms241512476
- By:
- Publication type:
- Article
Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1213716
- By:
- Publication type:
- Article
Systematic integration of m6A regulators and autophagy-related genes in combination with long non-coding RNAs predicts survival in glioblastoma multiforme.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44087-6
- By:
- Publication type:
- Article
Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1157366
- By:
- Publication type:
- Article
Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5626, doi. 10.3390/ijms24065626
- By:
- Publication type:
- Article
Marginalizing the genomic architecture to identify crosstalk across cancer and neurodegeneration.
- Published in:
- Frontiers in Molecular Neuroscience, 2023, v. 16, p. 1, doi. 10.3389/fnmol.2023.1155177
- By:
- Publication type:
- Article
Assessing the Effects of a Perioperative Nutritional Support and Counseling in Gastrointestinal Cancer Patients: A Retrospective Comparative Study with Historical Controls.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 609, doi. 10.3390/biomedicines11020609
- By:
- Publication type:
- Article
How shared is decision‐making in multidisciplinary tumour conferences with patient participation? An observational study.
- Published in:
- Health Expectations, 2022, v. 25, n. 6, p. 3297, doi. 10.1111/hex.13638
- By:
- Publication type:
- Article
Role of 18F-FDG PET/CT in patients affected by pulmonary primary lymphoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.973109
- By:
- Publication type:
- Article
Patient participation in multidisciplinary tumor conferences in breast and gynecological cancer care: How patient-centered is the communication?
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 9, p. 1597, doi. 10.1002/pon.5999
- By:
- Publication type:
- Article
Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.925633
- By:
- Publication type:
- Article
Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs) Harboring Oncogenic Potential and Is Markedly Upregulated in Hepatocellular Carcinoma.
- Published in:
- Biology (2079-7737), 2022, v. 11, n. 8, p. N.PAG, doi. 10.3390/biology11081174
- By:
- Publication type:
- Article
Extracellular Vesicles and Circulating Tumour Cells -- complementary liquid biopsies or standalone concepts?
- Published in:
- Theranostics, 2022, v. 12, n. 13, p. 5836, doi. 10.7150/thno.73400
- By:
- Publication type:
- Article
An Alternative Source for Allogeneic CAR T Cells With a High Safety Profile.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.913123
- By:
- Publication type:
- Article
A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.713476
- By:
- Publication type:
- Article
A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3783, doi. 10.3390/ijms23073783
- By:
- Publication type:
- Article
Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1311, doi. 10.3390/ijms23031311
- By:
- Publication type:
- Article
30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02184-2
- By:
- Publication type:
- Article
Immunoautophagy-Related Long Noncoding RNA (IAR-lncRNA) Signature Predicts Survival in Hepatocellular Carcinoma.
- Published in:
- Biology (2079-7737), 2021, v. 10, n. 12, p. 1301, doi. 10.3390/biology10121301
- By:
- Publication type:
- Article
Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6007, doi. 10.3390/cancers13236007
- By:
- Publication type:
- Article
value of bone marrow biopsy for staging of patients with primary CNS lymphoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2076, doi. 10.1093/neuonc/noab109
- By:
- Publication type:
- Article
NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.731767
- By:
- Publication type:
- Article
PPAR-Responsive Elements Enriched with Alu Repeats May Contribute to Distinctive PPARγ–DNMT1 Interactions in the Genome.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3993, doi. 10.3390/cancers13163993
- By:
- Publication type:
- Article
Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3375, doi. 10.3390/cancers13133375
- By:
- Publication type:
- Article
Improvements in Flow Cytometry‐Based Cytotoxicity Assay.
- Published in:
- Cytometry. Part A, 2021, v. 99, n. 7, p. 680, doi. 10.1002/cyto.a.24242
- By:
- Publication type:
- Article
Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-CTLA-4 therapy by bioinformatics.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1717, doi. 10.1007/s10637-020-00952-z
- By:
- Publication type:
- Article
Ten‐year update of the international registry on cytokine‐induced killer cells in cancer immunotherapy.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 12, p. 9291, doi. 10.1002/jcp.29827
- By:
- Publication type:
- Article
EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 3019, doi. 10.3390/cancers12103019
- By:
- Publication type:
- Article
Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2471, doi. 10.3390/cancers12092471
- By:
- Publication type:
- Article
Long‐term follow‐up of Cladribine, high‐dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 6, p. 538, doi. 10.1111/ejh.13395
- By:
- Publication type:
- Article
High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 3800, doi. 10.3390/ijms21113800
- By:
- Publication type:
- Article
Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 17, p. 4307, doi. 10.3390/ijms20174307
- By:
- Publication type:
- Article
Increase of CIK cell efficacy by upregulating cell surface MICA and inhibition of NKG2D ligand shedding in multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial Re LApsE.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 1, p. 42, doi. 10.1111/ejh.12888
- By:
- Publication type:
- Article
Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application.
- Published in:
- Scientia Pharmaceutica, 2017, v. 85, n. 1, p. 1, doi. 10.3390/scipharm85010008
- By:
- Publication type:
- Article
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effect of chaetocin on renal cell carcinoma cells and cytokine-induced killer cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta-catenin pathway.
- Published in:
- Hematological Oncology, 2014, v. 32, n. 4, p. 197, doi. 10.1002/hon.2122
- By:
- Publication type:
- Article
Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 8, p. 14632, doi. 10.3390/ijms150814632
- By:
- Publication type:
- Article